Lisdexamfetamine, marketed as Vyvanse, is a scheduled medication approved for attention deficit hyperactivity disorder in youngsters and grown-ups . In Canada, its availability is strictly regulated by https://lisdexamfetaminepharmacy337865.fireblogz.com/74818217/vyvanse-in-canada-a-complete-guide